Erratum to “Double-Blind, Randomized, Three-Armed, Placebo-Controlled, Clinical Investigation to Evaluate the Benefit and Tolerability of Two Dosages of IQP-AE-103 in Reducing Body Weight in Overweight and Moderately Obese Subjects”
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2019-01-01
|
| Series: | Journal of Obesity |
| Online Access: | http://dx.doi.org/10.1155/2019/6189724 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850177681634623488 |
|---|---|
| author | Ralf Uebelhack Udo Bongartz Stephanie Seibt Gordana Bothe Pee Win Chong Patricia De Costa Natalia Wszelaki |
| author_facet | Ralf Uebelhack Udo Bongartz Stephanie Seibt Gordana Bothe Pee Win Chong Patricia De Costa Natalia Wszelaki |
| author_sort | Ralf Uebelhack |
| collection | DOAJ |
| format | Article |
| id | doaj-art-c38738680a0f46128f99c848aca48fa8 |
| institution | OA Journals |
| issn | 2090-0708 2090-0716 |
| language | English |
| publishDate | 2019-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of Obesity |
| spelling | doaj-art-c38738680a0f46128f99c848aca48fa82025-08-20T02:18:55ZengWileyJournal of Obesity2090-07082090-07162019-01-01201910.1155/2019/61897246189724Erratum to “Double-Blind, Randomized, Three-Armed, Placebo-Controlled, Clinical Investigation to Evaluate the Benefit and Tolerability of Two Dosages of IQP-AE-103 in Reducing Body Weight in Overweight and Moderately Obese Subjects”Ralf Uebelhack0Udo Bongartz1Stephanie Seibt2Gordana Bothe3Pee Win Chong4Patricia De Costa5Natalia Wszelaki6Analyze & Realize GmbH, Weißenseer Weg 111, 10369 Berlin, GermanyAnalyze & Realize GmbH, Weißenseer Weg 111, 10369 Berlin, GermanyAnalyze & Realize GmbH, Waldseeweg 6, 13467 Berlin, GermanyAnalyze & Realize GmbH, Waldseeweg 6, 13467 Berlin, GermanyZaluvida Corporate Sdn Bhd, E-16 Plaza Mont Kiara, 2 Jalan Kiara, 50480 Kuala Lumpur, MalaysiaInQpharm Group Sdn Bhd, E-16 Plaza Mont Kiara, 2 Jalan Kiara, 50480 Kuala Lumpur, MalaysiaZaluvida Corporate Sdn Bhd, E-16 Plaza Mont Kiara, 2 Jalan Kiara, 50480 Kuala Lumpur, Malaysiahttp://dx.doi.org/10.1155/2019/6189724 |
| spellingShingle | Ralf Uebelhack Udo Bongartz Stephanie Seibt Gordana Bothe Pee Win Chong Patricia De Costa Natalia Wszelaki Erratum to “Double-Blind, Randomized, Three-Armed, Placebo-Controlled, Clinical Investigation to Evaluate the Benefit and Tolerability of Two Dosages of IQP-AE-103 in Reducing Body Weight in Overweight and Moderately Obese Subjects” Journal of Obesity |
| title | Erratum to “Double-Blind, Randomized, Three-Armed, Placebo-Controlled, Clinical Investigation to Evaluate the Benefit and Tolerability of Two Dosages of IQP-AE-103 in Reducing Body Weight in Overweight and Moderately Obese Subjects” |
| title_full | Erratum to “Double-Blind, Randomized, Three-Armed, Placebo-Controlled, Clinical Investigation to Evaluate the Benefit and Tolerability of Two Dosages of IQP-AE-103 in Reducing Body Weight in Overweight and Moderately Obese Subjects” |
| title_fullStr | Erratum to “Double-Blind, Randomized, Three-Armed, Placebo-Controlled, Clinical Investigation to Evaluate the Benefit and Tolerability of Two Dosages of IQP-AE-103 in Reducing Body Weight in Overweight and Moderately Obese Subjects” |
| title_full_unstemmed | Erratum to “Double-Blind, Randomized, Three-Armed, Placebo-Controlled, Clinical Investigation to Evaluate the Benefit and Tolerability of Two Dosages of IQP-AE-103 in Reducing Body Weight in Overweight and Moderately Obese Subjects” |
| title_short | Erratum to “Double-Blind, Randomized, Three-Armed, Placebo-Controlled, Clinical Investigation to Evaluate the Benefit and Tolerability of Two Dosages of IQP-AE-103 in Reducing Body Weight in Overweight and Moderately Obese Subjects” |
| title_sort | erratum to double blind randomized three armed placebo controlled clinical investigation to evaluate the benefit and tolerability of two dosages of iqp ae 103 in reducing body weight in overweight and moderately obese subjects |
| url | http://dx.doi.org/10.1155/2019/6189724 |
| work_keys_str_mv | AT ralfuebelhack erratumtodoubleblindrandomizedthreearmedplacebocontrolledclinicalinvestigationtoevaluatethebenefitandtolerabilityoftwodosagesofiqpae103inreducingbodyweightinoverweightandmoderatelyobesesubjects AT udobongartz erratumtodoubleblindrandomizedthreearmedplacebocontrolledclinicalinvestigationtoevaluatethebenefitandtolerabilityoftwodosagesofiqpae103inreducingbodyweightinoverweightandmoderatelyobesesubjects AT stephanieseibt erratumtodoubleblindrandomizedthreearmedplacebocontrolledclinicalinvestigationtoevaluatethebenefitandtolerabilityoftwodosagesofiqpae103inreducingbodyweightinoverweightandmoderatelyobesesubjects AT gordanabothe erratumtodoubleblindrandomizedthreearmedplacebocontrolledclinicalinvestigationtoevaluatethebenefitandtolerabilityoftwodosagesofiqpae103inreducingbodyweightinoverweightandmoderatelyobesesubjects AT peewinchong erratumtodoubleblindrandomizedthreearmedplacebocontrolledclinicalinvestigationtoevaluatethebenefitandtolerabilityoftwodosagesofiqpae103inreducingbodyweightinoverweightandmoderatelyobesesubjects AT patriciadecosta erratumtodoubleblindrandomizedthreearmedplacebocontrolledclinicalinvestigationtoevaluatethebenefitandtolerabilityoftwodosagesofiqpae103inreducingbodyweightinoverweightandmoderatelyobesesubjects AT nataliawszelaki erratumtodoubleblindrandomizedthreearmedplacebocontrolledclinicalinvestigationtoevaluatethebenefitandtolerabilityoftwodosagesofiqpae103inreducingbodyweightinoverweightandmoderatelyobesesubjects |